Expert believes Minister should 'stick with system' after allowing all cervical cancer sufferers access to expensive drug

The head of the National Centre of Pharmaeconomics thinks the Minister for Health Simon Harris should “stick with the system” when it comes to approving access to expensive drugs.

Professor Michael Barry was commenting on the decision to make the cervical cancer drug Pembrol available to all women with cervical cancer, not just the 221 affected by the CervicalCheck controversy.